To this end, we first demonstrated that USP22 knockdown could abrogate high MYH9-induced HIF-1α upregulation and promote ubiquitin-mediated degradation of HIF-1α in the HCC parent type or LR cells (Fig. 7a, b). The gene discussed is USP22; the disease is hepatocellular carcinoma.